Nephrosant Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Employees
  • 54

Employees

  • Latest Deal Type
  • Out of Business

Nephrosant General Information

Description

Developer of a urine-based diagnostic tool designed to predict and prevent the progression of kidney disease. The company's tool permits quantitative measurement of biomarkers for the early detection and lifetime monitoring of kidney disease, enabling physicians to detect acute rejection of kidney transplants noninvasively.

Contact Information

Website
www.nephrosant.com
Formerly Known As
KIT Bio
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 150 North Hill Drive
  • Suite 10
  • Brisbane, CA 94005
  • United States
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Corporate Office
  • 150 North Hill Drive
  • Suite 10
  • Brisbane, CA 94005
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nephrosant Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 12-Feb-2024 Completed Out of Business
4. Grant 14-May-2021 Completed Generating Revenue
3. Later Stage VC (Series A) 30-Oct-2020 Completed Generating Revenue
2. Seed Round 18-Mar-2020 $6.1M $6.1M Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2019 Completed Startup
To view Nephrosant’s complete valuation and funding history, request access »

Nephrosant Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a urine-based diagnostic tool designed to predict and prevent the progression of kidney disease. The compan
Diagnostic Equipment
Brisbane, CA
54 As of 2022

Lenexa, KS
 

Austin, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nephrosant Competitors (3)

One of Nephrosant’s 3 competitors is Transplant Genomics, a Formerly VC-backed company based in Lenexa, KS.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Transplant Genomics Formerly VC-backed Lenexa, KS
Natera Formerly VC-backed Austin, TX
CareDx Formerly VC-backed Brisbane, CA
You’re viewing 3 of 3 competitors. Get the full list »

Nephrosant Patents

  • 16

    Total Documents Applications and Grants

  • Total Patents Families

  • 8

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

Nephrosant Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240426819-A1 Lateral flow device for allograft rejection Pending 26-Jun-2023
AU-2022399364-A1 Generative adversarial network for urine biomarkers Pending 30-Nov-2021
EP-4440429-A1 Generative adversarial network for urine biomarkers Pending 30-Nov-2021
EP-4440429-A4 Generative adversarial network for urine biomarkers Pending 30-Nov-2021
WO-2023101886-A1 Generative adversarial network for urine biomarkers Inactive 30-Nov-2021 G16H50/20
To view Nephrosant’s complete patent history, request access »

Nephrosant Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Nephrosant FAQs

  • When was Nephrosant founded?

    Nephrosant was founded in 2015.

  • Where is Nephrosant headquartered?

    Nephrosant is headquartered in Brisbane, CA.

  • What is the size of Nephrosant?

    Nephrosant has 54 total employees.

  • What industry is Nephrosant in?

    Nephrosant’s primary industry is Diagnostic Equipment.

  • Is Nephrosant a private or public company?

    Nephrosant is a Private company.

  • What is Nephrosant’s current revenue?

    The current revenue for Nephrosant is .

  • How much funding has Nephrosant raised over time?

    Nephrosant has raised $22.1M.

  • Who are Nephrosant’s competitors?

    Transplant Genomics, Natera, and CareDx are competitors of Nephrosant.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process